Antimicrobial activity of Lactobacillus salivarius and Lactobacillus fermentum against Staphylococcus aureus

Pathogens and Disease

Volumn 75, Issue 2, 2017, Pages

  Kang, Mi Sun ^a,b   Lim, Hae Soon ^a,c   Oh, Jong Suk ^d   Lim, You Jin ^e   Wuertz Kozak, Karin ^f,g,h   Harro, Janette M ^a   Shirtliff, Mark E ^a,i   Achermann, Yvonne ^a,j  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b Research Institute Ltd   (South Korea)

^c Chonnam National University   (South Korea)

^d Chonnam National University Medical School   (South Korea)

^e Gwangju Health University   (South Korea)

^f ETH ZURICH   (Switzerland)

^g Institute of the Paracelsus Medical University 5020 Salzburg (Austria)   (Germany)

^h UNIVERSITY OF POTSDAM   (Germany)

ⁱ UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY HOSPITAL ZURICH   (Switzerland)

more..

Author keywords

Antibacterial activity; Biofilm; Lactobacillus fermentum; Lactobacillus salivarius; LysM; Staphylococcus aureus

Indexed keywords

BACTERIAL PROTEIN; PEPTIDASE; PEPTIDOGLYCAN; PROTEINASE K; ANTIINFECTIVE AGENT; RNA 16S;

ACIDIFICATION; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BIOFILM; CONTROLLED STUDY; LACTOBACILLUS FERMENTUM; LACTOBACILLUS SALIVARIUS; NONHUMAN; NUTRIENT; PLANKTON; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEOMICS; STAPHYLOCOCCUS AUREUS; SUPERNATANT; ANTIBIOSIS; CLASSIFICATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL VIABILITY; MICROBIOLOGY; MOUTH; PHYSIOLOGY; SECRETION (PROCESS);

ANTI-BACTERIAL AGENTS; ANTIBIOSIS; BACTERIAL PROTEINS; BIOFILMS; HUMANS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS SALIVARIUS; MICROBIAL VIABILITY; MOUTH; RNA, RIBOSOMAL, 16S; STAPHYLOCOCCUS AUREUS;

EID: 85020319551     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1093/femspd/ftx009     Document Type: Article

References (47)

1. Achermann Y, Tran B, Kang M et al. Immunoproteomic identification of in vivo-produced Propionibacterium acnes proteins in a rabbit biofilm infection model. Clin Vaccine Immunol 2015;22:467-76
2. Alvarez-Olmos MI, Oberhelman RA. Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis 2001;32:1567-76
3. Anderl JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Ch 2000;44:1818-24
4. Baek KT, Frees D, Renzoni A et al. Genetic variation in the Staphylococcus aureus 8325 strain lineage revealed by whole-genome sequencing. PLoS One 2013;8:e77122
5. Bessesen MT, Kotter CV,Wagner BD et al. MRSA colonization and the nasal microbiome in adults at high risk of colonization and infection. J Infect 2015;71:649-57
6. Boris S, Suárez JE, Barbés C. Characterization of the aggregation promoting factor from Lactobacillus gasseri, a vaginal isolate. J Appl Microbiol 1997;83:413-20
7. Brady RA, Leid JG, Camper AK et al. Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection. Infect Immun 2006;74: 3415-26
8. Buist G, Steen A, Kok J et al. LysM, a widely distributed protein motif for binding to (peptido)glycans. Mol Microbiol 2008;68:838-47
9. Buist G, Kok J, Leenhouts KJ et al. Molecular cloning and nucleotide sequence of the gene encoding the major peptidoglycan hydrolase of Lactococcus lactis, a muramidase needed for cell separation. J Bacteriol 1995;177:1554-63
10. Cassat J, Dunman PM, Murphy E et al. Transcriptional profiling of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390. Microbiology 2006;152:3075-90
11. Ceri H, OlsonME, Turner RJ. Needed, newparadigms in antibiotic development. Expert Opin Pharmaco 2010;11:1233-7
12. Chen LJ, Tsai HT, Chen WJ et al. In vitro antagonistic growth effects of Lactobacillus fermentum and lactobacillus salivarius and their fermentative broth on periodontal pathogens. Braz JMicrobiol 2012;43:1376-84
13. Dennis VA, Dixit S, O'Brien SM et al. Live Borrelia burgdorferi spirochetes elicit inflammatory mediators from human monocytes via the Toll-like receptor signaling pathway. Infect Immun 2009;77:1238-45
14. Diep BA, Gill SR, Chang RF et al. Complete genome sequence of USA300, an epidemic clone of communityacquired methicillin-resistant Staphylococcus aureus. Lancet 2006;367:731-9
15. Dobson A, Cotter PD, Ross RP et al. Bacteriocin production: a probiotic trait?. Appl Environ Microb 2012;78:1-6
16. Drago L, De Vecchi E, Gabrieli A et al. Immunomodulatory effects of Lactobacillus salivarius LS01 and Bifidobacterium breve BR03, alone and in combination, on peripheral blood mononuclear cells of allergic asthmatics. Allergy Asthma Immunol Res 2015;7:409-13
17. Eggers S, Barker A, Valentine S et al. Impact of Probiotics for Reducing Infections in Veterans (IMPROVE): Study protocol for a double-blind, randomized controlled trial to reduce carriage of Staphylococcus aureus. Contemp Clin Trials 2016;52:39-45
18. Fernández L, Cárdenas N, Arroyo R et al. Prevention of infectious mastitis by oral administration of Lactobacillus salivarius PS2 during late pregnancy. Clin Infect Dis 2016;62:568-73
19. Flynn S, van Sinderen D, Thornton GM et al. Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium Lactobacillus salivarius subsp. salivarius UCC118. Microbiology 2002;148:973-84
20. Glück U, Gebbers JO. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr 2003;77:517-20
21. Harro JM, Daugherty S, Bruno VMet al. Draft genome sequence of the methicillin-resistant Staphylococcus aureus isolate MRSAM2. Genome Announc 2013;1:e00037-12
22. Hevia A, Martinez N, Ladero V et al. An extracellular Serine/Threonine-rich protein from Lactobacillus plantarum NCIMB 8826 is a novel aggregation-promoting factor with affinity to mucin. Appl Environ Microb 2013;79:6059-66
23. Kang MS, Oh JS, Lee SW et al. Effect of Lactobacillus reuteri on the proliferation of Propionibacterium acnes and Staphylococcus epidermidis. J Microbiol 2012;50:137-42
24. Kang MS, Kim JH, Shin BA et al. Inhibitory effect of chlorophyllin on the Propionibacterium acnes-induced chemokine expression. J Microbiol 2013;51:844-9
25. Karska-Wysocki B, Bazo M, Smoragiewicz W. Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA). Microbiol Res 2010;165:674-86
26. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007;13:1840-6
27. Klevens RM et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298:1763-71
28. Li Y, Raftis E, Canchaya C et al. Polyphasic analysis indicates that Lactobacillus salivarius subsp. salivarius and Lactobacillus salivarius subsp. salicinius do not merit separate subspecies status. Int J Syst Evol Micr 2006;56(Pt 10):2397-403
29. Lowy FD. Staphylococcus aureus infections. New Engl J Med 1998;339:520-32
30. Messaoudi S, Manai M, Kergourlay G et al. Lactobacillus salivarius: bacteriocin and probiotic activity. Food Microbiol 2013;36:296-304
31. Montoiro Allué R, Moreno Loshuertos S, Sánchez Marteles M. Infectious endocarditis, pneumonia, bacteremia, and meningitis caused by Staphylococcus aureus in a patient with terminal kidney disease: a case study. Nefrologia 2010;30:485-6
32. Olivares M, Díaz-Ropero MP, Martín R et al. Antimicrobial potential of four Lactobacillus strains isolated from breast milk. J Appl Microbiol 2006;101:72-9
33. Plaut RD, Mocca CP, Prabhakara R et al. Stably luminescent Staphylococcus aureus clinical strains for use in bioluminescent imaging. PLoS One 2013;8:e59232
34. Pridmore RD, Pittet AC, Praplan F et al. Hydrogen peroxide production by Lactobacillus johnsonii NCC 533 and its role in anti-Salmonella activity. FEMS Microbiol Lett 2008;283: 210-5
35. Reid G, WHO and Food and Agricultural Organization of the United Nation. The importance of guidelines in the development and application of probiotics. Curr Pharm Des 2005;11: 11-6
36. Sánchez B, Chaignepain S, Schmitter JM et al. A method for the identification of proteins secreted by lactic acid bacteria grown in complex media. FEMS Microbiol Lett 2009;295:226-9
37. Sikorska H, Smoragiewicz W. Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections. Int J Antimicrob Ag 2013;42:475-81
38. Silva M, Jacobus NV, Deneke C et al. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Ch 1987;31:1231-3
39. Simor AE, Ofner-Agostini M, Bryce E et al. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. CMAJ 2001;165:21-6
40. Stohl EA, Chan YA, Hackett KT et al. Neisseria gonorrhoeae virulence factor NG1686 is a bifunctional M23B family metallopeptidase that influences resistance to hydrogen peroxide and colony morphology. J Biol Chem 2012;287:11222-33
41. Treangen TJ, Maybank RA, Enke S et al. Complete genome sequence of the quality control strain Staphylococcus aureus subsp. aureus ATCC 25923. Genome Announc 2014;2:e01110-14
42. Turner MS, Hafner LM, Walsh T et al. Identification and characterization of the novel LysM domain-containing surface protein Sep from Lactobacillus fermentum BR11 and its use as a peptide fusion partner in Lactobacillus and Lactococcus. Appl Environ Microb 2004;70:3673-80
43. van Pijkeren JP, Canchaya C, Ryan KA et al. Comparative and functional analysis of sortase-dependent proteins in the predicted secretome of Lactobacillus salivarius UCC118. Appl Environ Microb 2006;72:4143-53
44. Varma P, Nisha N, Dinesh KR et al. Anti-infective properties of Lactobacillus fermentum against Staphylococcus aureus and Pseudomonas aeruginosa. J Mol Microb Biotech 2011;20:137-43
45. Weisburg WG, Barns SM, Pelletier DA et al. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 1991;173:697-703
46. Wertheim HF, Vos MC, Ott A et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004;364:703-05
47. Wilson T, Carson J. Rapid, high-throughput extraction of bacterial genomic DNA from selective-enrichment culture media. Lett Appl Microbiol 2001;32:326-30